De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Mahickra Chemicals Toekomstige groei

Future criteriumcontroles 0/6

Momenteel beschikken we niet over voldoende analisten om de groei en omzet voor Mahickra Chemicals te voorspellen.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Chemicals winstgroei	20.8%
Inkomstengroei	n/a
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	None
Laatst bijgewerkt	n/a

Recente toekomstige groei-updates

Geen updates

Recent updates

Mahickra Chemicals Limited's (NSE:MAHICKRA) Share Price Not Quite Adding Up

Jul 02

There's Reason For Concern Over Mahickra Chemicals Limited's (NSE:MAHICKRA) Massive 29% Price Jump

Jan 30

We Think Mahickra Chemicals (NSE:MAHICKRA) Is Taking Some Risk With Its Debt

Jan 19

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Jun 14

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Apr 04

There's A Lot To Like About Mahickra Chemicals' (NSE:MAHICKRA) Upcoming ₹0.20 Dividend

Feb 27

Insider Buying: The Mahickra Chemicals Limited (NSE:MAHICKRA) Chairman & MD Just Bought ₹121k Worth Of Shares

Feb 06

How Does Mahickra Chemicals Limited (NSE:MAHICKRA) Stand Up To These Simple Dividend Safety Checks?

Jan 31

Should You Take Comfort From Insider Transactions At Mahickra Chemicals Limited (NSE:MAHICKRA)?

Jan 04

Mahickra Chemicals Limited's (NSE:MAHICKRA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Nov 29

In dit gedeelte presenteren we gewoonlijk prognoses voor de omzet- en winstgroei op basis van de consensusramingen van professionele analisten om beleggers te helpen begrijpen in hoeverre het bedrijf in staat is winst te genereren. Maar omdat Mahickra Chemicals onvoldoende gegevens uit het verleden heeft verstrekt en geen analistenprognose heeft, kan de toekomstige winst niet betrouwbaar worden berekend door gegevens uit het verleden te extrapoleren of analistenprognoses te gebruiken.

Dit is een vrij zeldzame situatie, aangezien 97% van de bedrijven die worden gedekt door SimplyWall St wel financiële gegevens uit het verleden hebben.

Winst- en omzetgroeiprognoses

NSEI:MAHICKRA - Toekomstschattingen van analisten en financiële gegevens uit het verleden (INR Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
3/31/2024	735	11	-11	-4	N/A
12/31/2023	799	16	N/A	N/A	N/A
9/30/2023	863	22	-42	-35	N/A
6/30/2023	958	27	-14	-6	N/A
3/31/2023	1,054	33	15	23	N/A
12/31/2022	1,115	33	N/A	N/A	N/A
9/30/2022	1,176	33	32	43	N/A
6/30/2022	1,113	33	26	38	N/A
3/31/2022	1,049	33	19	32	N/A
12/31/2021	1,013	35	N/A	N/A	N/A
9/30/2021	976	37	N/A	N/A	N/A
6/30/2021	931	34	N/A	N/A	N/A
3/31/2021	886	31	-31	-25	N/A
12/31/2020	849	27	N/A	N/A	N/A
9/30/2020	813	23	N/A	N/A	N/A
6/30/2020	889	26	N/A	N/A	N/A
3/31/2020	964	30	-58	-35	N/A
12/31/2019	937	28	N/A	N/A	N/A
9/30/2019	909	26	N/A	N/A	N/A
6/30/2019	860	23	N/A	N/A	N/A
3/31/2019	812	20	-42	-42	N/A
12/31/2018	400	23	N/A	N/A	N/A
3/31/2018	197	7	-112	-112	N/A
3/31/2017	414	4	N/A	-2	N/A
3/31/2016	340	2	N/A	1	N/A
3/31/2015	422	1	N/A	7	N/A
3/31/2014	431	2	N/A	-17	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van MAHICKRA boven de spaarquote ( 6.7% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van MAHICKRA naar verwachting sneller zal groeien dan de markt Indian

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van MAHICKRA naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: Er zijn onvoldoende gegevens om te bepalen of de omzet van MAHICKRA naar verwachting sneller zal groeien dan de markt Indian.

Hoge groei-inkomsten: Er zijn onvoldoende gegevens om te bepalen of de omzet van MAHICKRA naar verwachting sneller zal groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van MAHICKRA naar verwachting over 3 jaar hoog zal zijn

Mahickra Chemicals Toekomstige groei

Future criteriumcontroles 0/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Mahickra Chemicals Limited, Annual General Meeting, Sep 21, 2024

Whole-Time Director recently sold ₹5.0m worth of stock

Whole-Time Director recently sold ₹7.7m worth of stock

New minor risk - Insider selling

Whole-Time Director recently sold ₹599k worth of stock

Mahickra Chemicals Limited's (NSE:MAHICKRA) Share Price Not Quite Adding Up

New major risk - Market cap size

Whole-Time Director recently sold ₹311k worth of stock

Chairman & MD recently sold ₹533k worth of stock

Full year 2024 earnings released: EPS: ₹1.32 (vs ₹4.05 in FY 2023)

Chairman & MD recently bought ₹1.3m worth of stock

New minor risk - Share price stability

New minor risk - Share price stability

Chairman & MD recently bought ₹931k worth of stock

Investor sentiment improves as stock rises 21%

There's Reason For Concern Over Mahickra Chemicals Limited's (NSE:MAHICKRA) Massive 29% Price Jump

We Think Mahickra Chemicals (NSE:MAHICKRA) Is Taking Some Risk With Its Debt

Whole-Time Director recently bought ₹157k worth of stock

First half 2024 earnings released: EPS: ₹0.60 (vs ₹1.95 in 1H 2023)

New major risk - Financial position

Whole-Time Director recently bought ₹500k worth of stock

Mahickra Chemicals Limited, Annual General Meeting, Aug 29, 2023

Chairman & MD recently bought ₹124k worth of stock

New minor risk - Share price stability

Chairman & MD recently bought ₹251k worth of stock

Whole-Time Director recently bought ₹125k worth of stock

Chairman & MD recently bought ₹134k worth of stock

Chairman & MD recently bought ₹148k worth of stock

Whole-Time Director recently bought ₹148k worth of stock

Investor sentiment improves as stock rises 18%

Chairman & MD recently bought ₹127k worth of stock

Chairman & MD recently bought ₹368k worth of stock

Chairman & MD recently bought ₹111k worth of stock

Chairman & MD recently bought ₹112k worth of stock

First half 2023 earnings released: EPS: ₹1.95 (vs ₹2.05 in 1H 2022)

Whole-Time Director recently bought ₹214k worth of stock

Whole-Time Director recently bought ₹100k worth of stock

Whole-Time Director recently bought ₹106k worth of stock

Whole-Time Director recently bought ₹216k worth of stock

Whole-Time Director recently bought ₹109k worth of stock

Chairman & MD recently bought ₹214k worth of stock

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Full year 2022 earnings released: EPS: ₹4.12 (vs ₹3.83 in FY 2021)

Insufficient new directors

Whole-Time Director recently bought ₹118k worth of stock

Chairman & MD recently bought ₹373k worth of stock

Whole-Time Director recently bought ₹121k worth of stock

Whole-Time Director recently bought ₹127k worth of stock

Chairman & MD recently bought ₹120k worth of stock

Chairman & MD recently bought ₹121k worth of stock

Chairman & MD recently bought ₹120k worth of stock

Whole-Time Director recently bought ₹119k worth of stock

Chairman & MD recently bought ₹120k worth of stock

First half 2022 earnings released

Chairman & MD recently bought ₹119k worth of stock

Whole-Time Director recently bought ₹120k worth of stock

Whole-Time Director recently bought ₹129k worth of stock

Chairman & MD recently bought ₹131k worth of stock

If You Like EPS Growth Then Check Out Mahickra Chemicals (NSE:MAHICKRA) Before It's Too Late

Whole-Time Director recently bought ₹120k worth of stock

Whole-Time Director recently bought ₹121k worth of stock

New 90-day low: ₹77.10

There's A Lot To Like About Mahickra Chemicals' (NSE:MAHICKRA) Upcoming ₹0.20 Dividend

Insider Buying: The Mahickra Chemicals Limited (NSE:MAHICKRA) Chairman & MD Just Bought ₹121k Worth Of Shares

Chairman & MD recently bought ₹121k worth of stock

New 90-day low: ₹78.45

How Does Mahickra Chemicals Limited (NSE:MAHICKRA) Stand Up To These Simple Dividend Safety Checks?

Should You Take Comfort From Insider Transactions At Mahickra Chemicals Limited (NSE:MAHICKRA)?

Mahickra Chemicals Limited's (NSE:MAHICKRA) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

New 90-day high: ₹84.25

Chairman & MD recently bought ₹113k worth of stock

New 90-day high: ₹80.00

Whole-Time Director recently bought ₹108k worth of stock

Chairman & MD recently bought ₹107k worth of stock

Whole-Time Director recently bought ₹107k worth of stock